Detection of dopamine D2 receptor mRNA and binding sites in monkey amniotic epithelial cells
✍ Scribed by M.A. Elwan; T. Ishii; N. Sakuragawa
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 106 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Previous results from our laboratory showed that monkey amniotic epithelial cells (MAEC) possess the catecholamine synthesizing enzymes and have the capacity to synthesize and release CA. Recently, we also reported that these cells express dopamine D 1 receptor mRNA and binding sites. This study was designed to investigate the presence of dopamine D 2 receptors in MAEC. Using RT-PCR, we found that MAEC express dopamine D 2 receptor mRNA that is having 98% homology with human dopamine D 2 receptors. Radioligand saturation binding studies showed a 3 H-YM-09151-2 high-affinity binding site with a K D of 0.293 ؎ 0.06 nM and Bmax of 180.69 ؎ 11.61 fmol/mg protein. Competition experiments with a variety of displacing drugs demonstrated that D 2 antagonists potently compete with 3 H-YM-09151-2 binding, whereas D 1 antagonists displayed a weaker competition for the binding sites. The rank order of potency of these compounds in competing with 3 H-YM-09151-2 for binding sites was consistent with the pharmacology of the dopamine D 2 receptors. All competition curves were better fitted to a one-site model with a Hill coefficient around unity, indicating that 3 H-YM-09151-2 is labeling a single population of receptors. These results provide, for the first time, a compelling evidence that MAEC natively express dopamine D 2 receptor mRNA and binding sites, and they suggest that monkey amniotic epithelial cells (MAEC) could represent a source of primate dopamine receptors without the need for transformation or cloning procedures using nonprimate cells, as generally happens.